Both ablation and various lifestyle modifications, like losing weight and exercising more, have roles to play, experts agree.

Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

Vektor Medical, a medical technology company transforming standard ECG data into actionable insights that guide arrhythmia ...

Introduction: Currently, the treatment of atrial fibrillation (AF) focuses on restoring sinus rhythm with pulmonary vein isolation (PVI). Pulsed-field ablation (PFA) is a novel, promising method that ...

Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ablation system.

The global varicose vein treatment market is estimated to be valued at USD 857.8 million in 2025 and is projected to reach USD 1,594.2 million by 2035, registering a compound annual growth rate of 6.4 ...

Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, ...

Vektor Medical doses first patients in IMPRoVED-AF study using vMap to guide effective atrial fibrillation ablation: San Diego Friday, July 11, 2025, 15:00 Hrs [IST] San Diego-hea ...

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...

Boston Scientific (NYSE: BSX) announced that the FDA approved an expansion to the label of its Farapulse pulsed field ablation (PFA) system.